• The Serum Institute of India (SII) and the Department of Biotechnology(DBT) are set to launch India's first indigenously developed Quadrivalent Human Papillomavirus vaccine (qHPV) against Cervical Cancer on September 1, official sources told ANI. (indiatimes.com)
  • Objectives To determine the effect of human papillomavirus (HPV) quadrivalent vaccine on the risk of developing subsequent disease after an excisional procedure for cervical intraepithelial neoplasia or diagnosis of genital warts, vulvar intraepithelial neoplasia, or vaginal intraepithelial neoplasia. (sanevax.org)
  • Participants Among 17 622 women aged 15-26 years who underwent 1:1 randomisation to vaccine or placebo, 2054 received cervical surgery or were diagnosed with genital warts, vulvar intraepithelial neoplasia, or vaginal intraepithelial neoplasia. (sanevax.org)
  • Results A total of 587 vaccine and 763 placebo recipients underwent cervical surgery. (sanevax.org)
  • Those followed for cervical disease included 2241 women (82%) in the vaccine group and 2258 (83%) in the placebo group. (elsevierpure.com)
  • In an intention-to-treat analysis, including those with prevalent infection or disease caused by vaccine-type and non-vaccine-type HPV, vaccination reduced the rate of any vulvar or vaginal perianal lesions regardless of the causal HPV type by 34% (95% confidence interval [CI], 15 to 49), and the rate of cervical lesions regardless of the causal HPV type by 20% (95% CI, 8 to 31). (elsevierpure.com)
  • All HPV vaccines protect against at least HPV types 16 and 18, which cause the greatest risk of cervical cancer. (wikipedia.org)
  • It is estimated that HPV vaccines may prevent 70% of cervical cancer, 80% of anal cancer, 60% of vaginal cancer, 40% of vulvar cancer, and show more than 90% efficacy in preventing HPV-positive oropharyngeal cancers. (wikipedia.org)
  • HPV vaccines are used to prevent HPV infection and therefore cervical cancer. (wikipedia.org)
  • Since the vaccines only cover some high-risk types of HPV, cervical cancer screening is recommended even after vaccination. (wikipedia.org)
  • The HPV vaccine has been shown to prevent cervical dysplasia from the high-risk HPV types 16 and 18 and provide some protection against a few closely related high-risk HPV types. (wikipedia.org)
  • Overall, about 30 percent of cervical cancers will not be prevented by these vaccines. (wikipedia.org)
  • Neither vaccine prevents other sexually transmitted diseases, nor do they treat existing HPV infection or cervical cancer. (wikipedia.org)
  • Background: A randomised double-blind placebo-controlled phase II study was done to assess the efficacy of a prophylactic quadrivalent vaccine targeting the human papillomavirus (HPV) types associated with 70% of cervical cancers (types 16 and 18) and with 90% of genital warts (types 6 and 11). (johnshopkins.edu)
  • The primary endpoint was the combined incidence of infection with HPV 6, 11, 16, or 18, or cervical or external genital disease (ie, persistent HPV infection, HPV detection at the last recorded visit, cervical intraepithelial neoplasia, cervical cancer, or external genital lesions caused by the HPV types in the vaccine). (johnshopkins.edu)
  • We included 153,250 girls born between 1989 and 1993, resident in Sweden since the introduction of HPV vaccines (October 2006) and attending cervical screening at age 23 years. (nature.com)
  • High-risk human papillomavirus (HPV) is the major cause of cervical cancer. (nature.com)
  • It is very effective and prevents cervical cancer because, 85 per cent to 90 per cent cases, cervical cancer is because of this particular virus and this vaccine is against those viruses. (indiatimes.com)
  • Assessment of the pre-human papillomavirus (HPV) vaccination burden of ambulatory care visits and procedures related to cervical cancer screening is provided, with projection of how HPV vaccination and testing may affect this burden. (ajmc.com)
  • Human papillomavirus vaccination and testing may affect the volume of Pap tests and cervical cancer procedures in the future. (ajmc.com)
  • Human papillomavirus (HPV) testing, approved for routine cervical cancer screening in 2003, and the HPV vaccine, approved for routine vaccination of girls in 2006, are shifting the paradigm of cervical cancer screening and management. (ajmc.com)
  • The development of a prophylactic vaccine to prevent infection with oncogenic subtypes of human papillomavirus (HPV) is an important step in reducing cervical cancer incidence and mortality. (aacrjournals.org)
  • In 2006, the U.S. Food and Drug Administration (FDA) approved the first HPV vaccine for administration to females 9 to 26 years of age for the prevention of cervical cancer ( 5, 6 ). (aacrjournals.org)
  • All three HPV vaccines protect against the two types of HPV (types 16 and 18) that cause about 70% of cervical cancers and 90% of anal cancers. (msdmanuals.com)
  • The aim of this study was to assess the cost-effectiveness of adding vaccination with the human papillomavirus 16/18 vaccine to the current cervical cancer screening program in Hungary. (biomedcentral.com)
  • Our modeling analysis showed that the vaccination of 12-year-old adolescent girls against cervical cancer with the AS04-adjuvanted human papillomavirus 16/18 vaccine would be a cost-effective strategy to prevent cervical cancer in Hungary. (biomedcentral.com)
  • Since the introduction of human papillomavirus (HPV) vaccines, both primary and secondary preventive (i.e., screening) measures have been available to prevent cervical cancer. (biomedcentral.com)
  • There are two vaccines available for preventing cervical cancer. (biomedcentral.com)
  • The purpose of this study was to assess the cost-effectiveness of adding vaccination with the AS04-adjuvanted human papillomavirus 16/18 vaccine (Cervarix TM ) at age 12 to the current national cervical screening program. (biomedcentral.com)
  • GSK is the only company supplying three vaccines (pneumococcal, rotavirus, and cervical cancer vaccines) at reduced prices to Gavi. (globalhealthprogress.org)
  • The major risk factor associated with cervical cancer is human papillomavirus (HPV) infection which generally occurs in adolescence after the first acts of sexual intercourse. (who.int)
  • The human papillomavirus (HPV) vaccine is used on a large scale in immunization programs in more than 58 countries, with resultant efficacy and safety for precursor lesions of cervical cancer, in addition to anogenital lesions. (bvsalud.org)
  • After the introduction of quadrivalent HPV vaccine (6,11,16 and 18) in Brazil in 2014, monitoring the vaccination coverage and the development of HPV prevalence incidence of cervical abnormalities and precancerous lesions must be observed, as well as morbidity and mortality trends from in situ and invasive cancer. (bvsalud.org)
  • Encouraging information, counseling and continuing education is recommended as a strategy to broaden vaccine acceptance in order to sediment its implementation and ensure effectiveness in reducing new cases of cervical cancer in the future. (bvsalud.org)
  • The two currently licensed human papillomavirus (HPV) vaccines are highly efficacious in preventing cervical pre-cancers related to HPV 6, 11, 16 and 18. (who.int)
  • Studies have shown that infection with high-risk human papillomavirus (HPV) can lead to cervical cancer. (who.int)
  • administration of HPV vaccine, the du- in each region, 1 middle school from ration of protection, vaccine side-effects the large cities of the region and 1 from In Morocco, cervical cancer represents and the indications for males. (who.int)
  • The standardized incidence of cervical the HPV vaccine ( 12 , 13 ). (who.int)
  • For these recommendations, ACIP considered information on vaccine efficacy (including data available since October 2009, on prevention of grade 2 or 3 anal intraepithelial neoplasia [AIN2/3], a precursor of anal cancer), vaccine safety, estimates of disease and cancer resulting from HPV, cost-effectiveness, and programmatic considerations. (cdc.gov)
  • Efficacy for prevention of HPV 6-, 11-, 16- and 18-related genital warts among males who received at least 1 vaccine dose, regardless of baseline infection or serology (intent to treat population), was 68.1% (CI = 48.8%-80.7%) ( 4 ). (cdc.gov)
  • BACKGROUND: A phase 3 trial was conducted to evaluate the efficacy of a prophylactic quadrivalent vaccine in preventing anogenital diseases associated with human papillomavirus (HPV) types 6, 11, 16, and 18. (elsevierpure.com)
  • Vaccine efficacy was 100% for each of the coprimary end points. (elsevierpure.com)
  • To assess its efficacy and safety, the manufacturer of quadrivalent human papillomavirus (qHPV) vaccine conducted multiple clinical trials involving approximately 30,000 volunteers. (umaryland.edu)
  • Vaccination efficacy was assumed to be 100%, based on trials showing high efficacy of prophylactic HPV vaccines against persistent infection and vaccine type-specific CIN 2 and 3 (5-9). (cdc.gov)
  • High sustained efficacy of a prophylactic quadrivalent human papillomavirus types 6/11/16/18 L1 virus-like particle vaccine through 5 years of follow-up. (vakciny.net)
  • We report data for the longest efficacy evaluation to date of a prophylactic HPV vaccine. (vakciny.net)
  • Vaccine efficacy in men and women suggests that immunization is more effective among individuals who have not been infected with HPV and reduces the morbidity of young women related to precursor lesions and cancer in situ 8 . (bvsalud.org)
  • Cuba COVID-19 vaccine is a conjugate vaccine in which the virus antigen, the receptor-binding domain, is chemically bound to the tetanus toxoid. (precisionvaccinations.com)
  • As of 2017, Gardasil 9 is the only HPV vaccine available in the United States, as it provides protection against more HPV types than the earlier approved vaccines (the original Gardasil and Cervarix). (wikipedia.org)
  • Three HPV vaccines (Gardasil, Gardasil 9, and Cervarix) are licensed and recommended for use in females. (cdc.gov)
  • One of these is Cervarix TM , an AS04-adjuvanted bivalent vaccine against HPV types 16 and 18 produced by GlaxoSmithKline. (biomedcentral.com)
  • Cervarix is a non-infectious recombinant, AS04-adjuvanted vaccine, that contains recombinant L1 protein, the major antigenic protein of the capsid, of oncogenic HPV types 16 and 18. (precisionvaccinations.com)
  • In 2018, they distributed around two million doses of the vaccine Cervarix in Zimbabwe in support of its multi-age cohort vaccination program to protect over 800,000 girls against human papillomavirus and have also supported Gavi pilots of our Cervarix vaccine for human papillomavirus (HPV) in 12 countries since 2012. (globalhealthprogress.org)
  • Not all vulvar and vaginal cancers are caused by human papillomavirus (HPV), and GARDASIL protects only against those vulvar and vaginal cancers caused by HPV types 16 and 18. (salesandmarketingnetwork.com)
  • Three vaccines are routinely recommended for adolescents to prevent pertussis, meningococcal disease, and cancers caused by human papillomavirus (HPV). (cdc.gov)
  • Human papillomavirus (HPV) vaccines are vaccines that prevent infection by certain types of human papillomavirus (HPV). (wikipedia.org)
  • Interpretation: A vaccine targeting HPV types 6, 11, 16, 18 could substantially reduce the acquisition of infection and clinical disease caused by common HPV types. (johnshopkins.edu)
  • The current HPV vaccine recommendations apply to 9 years old and above through the age of 26 years and adults aged 27-45 years who might be at risk of new HPV infection and benefit from vaccination. (mdpi.com)
  • Despite weak knowledge of genital warts and HPV infection, acceptability of the HPV vaccine was 76.8% (95% CI: 73.3-79.9%) among mothers and 68.9% (95% CI: 65.2-72.5%) among fathers. (who.int)
  • Human Papillomavirus (HPV) Infection Human papillomavirus (HPV) can be sexually transmitted and causes changes in cells, which can lead to genital warts or to precancer or cancer of the cervix, vagina, vulva, anus, or throat. (msdmanuals.com)
  • The vaccine does not contain any live virus and thus cannot cause HPV infection. (msdmanuals.com)
  • Human papillomavirus (HPV) infection is one of the most common sexually transmitted infections in the United States. (cdc.gov)
  • As a vaccine becomes more widely used, the national prevalence of HPV infection will be critical for evaluating vaccination strategies in the United States. (cdc.gov)
  • At 5 years post enrollment, the combined incidence of HPV 6/11/16/18-related persistent infection or disease was reduced in vaccine-recipients by 96% (two cases vaccine versus 46 placebo). (vakciny.net)
  • Through 5 years, vaccine-induced anti-HPV geometric mean titres remained at or above those following natural infection. (vakciny.net)
  • In conclusion, a prophylactic quadrivalent HPV vaccine was effective through 5 years for prevention of persistent infection and disease caused by HPV 6/11/16/18. (vakciny.net)
  • Before implementing a large-scale HPV vaccine campaign in Viet Nam, information about the prevalence of infection with the HPV vaccine types is required. (who.int)
  • While it is relevant to implement an HPV vaccine campaign in Viet Nam due to the high prevalence of infection with HPV 16 and/or 18, it is important to note that one can be infected with multiple types of HPV. (who.int)
  • Introduction: The complications caused by the infections of hepatitis B virus and human papillomavirus (HPV) are important public health problems in Brazil and the world. (usp.br)
  • Conclusions Previous vaccination with quadrivalent HPV vaccine among women who had surgical treatment for HPV related disease significantly reduced the incidence of subsequent HPV related disease, including high grade disease. (sanevax.org)
  • No autoimmune safety signal after vaccination with quadrivalent HPV vaccine Gardasil? (greatergoodmovie.org)
  • The nine-valent and quadrivalent vaccines protect against the two types of HPV (types 6 and 11) that cause more than 90% of genital warts, in addition to protecting against types 16 and 18. (msdmanuals.com)
  • To summarize reports to the Vaccine Adverse Event Reporting System (VAERS) following receipt of qHPV. (nih.gov)
  • The trials of the qHPV vaccine are reported as 'placebo-controlled. (umaryland.edu)
  • AAHS is used in the qHPV vaccine to boost immune response, but the rationale for adding it to the 'placebo' is not reported in publications of these trials and is contrary to the advice of the public health bodies and regulators. (umaryland.edu)
  • Cervavac is India produced quadrivalent human papillomavirus vaccine qHPV. (precisionvaccinations.com)
  • ABSTRACT Data about the public's awareness and acceptability of the human papilloma virus (HPV) vaccine are lacking in the Eastern Mediterranean Region. (who.int)
  • They additionally prevent some genital warts, with the quadrivalent and nonavalent vaccines that protect against HPV types HPV-6 and HPV-11 providing greater protection. (wikipedia.org)
  • Also, in the case of Gardasil, ten percent of genital warts will not be prevented by the vaccine. (wikipedia.org)
  • Substantial declines in genital warts (GW) have been observed in countries with quadrivalent HPV vaccination programmes, with Australia showing the highest reductions due to early commencement and high vaccination coverage. (mdpi.com)
  • Countries that have adopted the quadrivalent vaccine have reported reduction of precursor lesions from 60-80%, with rates of 100% in populations vaccinated with the quadrivalent vaccine (6, 11, 16 and 18) for cases of genital warts 5-7 . (bvsalud.org)
  • There was a decline in HPV 16/18 ( p = 0.004) but not in HPV 6/11 ( p = 0.172) in the post-vaccination period among men who recently arrived in Australia from countries with a bivalent vaccine programme. (bmj.com)
  • The decline in HPV 16/18, but not in HPV 6/11 among overseas-born males predominantly from countries with a bivalent vaccine programme, suggests these men receive herd protection for 16/18 from their vaccinated female partners in their countries of origin. (bmj.com)
  • In certain circumstances in which a single vaccine type is being used (e.g., in preparation for a community influenza vaccination campaign), filling a small number (10 or fewer) of syringes may be considered (5). (cdc.gov)
  • and Flucelvax, the first cell-culture derived influenza vaccine approved in the U.S., designed to protect adults 18 years and older against seasonal flu. (genengnews.com)
  • Thimerosal is currently used only in multidose vials of influenza vaccine, and exposure through vaccines is not associated with adverse neurologic outcomes. (aafp.org)
  • The virosomal influenza vaccine Invivac: immunogenicity and tolerability compared to an adjuvanted influenza vaccine (Fluad in elderly subjects. (vakciny.net)
  • The incidence of any subsequent HPV related disease was 6.6 and 12.2 in vaccine and placebo recipients respectively (46.2% reduction (95% confidence interval 22.5% to 63.2%) with vaccination). (sanevax.org)
  • CONCLUSIONS: The quadrivalent vaccine significantly reduced the incidence of HPV-associated anogenital diseases in young women. (elsevierpure.com)
  • Trials suggest that HPV vaccines may also reduce the incidence of adenocarcinoma. (wikipedia.org)
  • More research is needed, particularly regarding the incidence of vaccine-preventable infectious diseases and the safety of vaccination in patients with AIIRD. (bmj.com)
  • Family physicians should gather accurate information about the harms and benefits of vaccines to advocate for vaccination and decrease the incidence of vaccine-preventable diseases. (aafp.org)
  • 3 The fourth dose of the diphtheria and tetanus toxoids and acellular pertussis (DTaP) vaccine is associated with an increased incidence of fever and injection site reactions compared with the first dose (one in four children). (aafp.org)
  • A study by Nielsen et al examined trends in incidence of anal cancer and high-grade anal intraepithelial neoplasia in Denmark from 1978-2008 and found that HPV vaccines may be a vital factor in the prevention of anal cancer and its precursor lesions. (medscape.com)
  • The primary purpose of the current study is to report on national acceptability of the HPV vaccine among U.S. adults with female children in the household and to investigate the health behavior correlates of vaccine acceptability. (aacrjournals.org)
  • WHITEHOUSE STATION, N.J., Jan. 9, 2009 -(HSMN NewsFeed)- Merck & Co., Inc. announced today that the U.S. Food and Drug Administration has issued a second complete response letter regarding the supplemental biologics license application (sBLA) for the use of GARDASIL [Human Papillomavirus Quadrivalent (Types 6, 11, 16, 18) Vaccine, Recombinant] in women ages 27 though 45. (salesandmarketingnetwork.com)
  • Established in 1891, Merck currently discovers, develops, manufactures and markets vaccines and medicines to address unmet medical needs. (salesandmarketingnetwork.com)
  • In the per-protocol population, those followed for vulvar, vaginal, or perianal disease included 2261 women (83%) in the vaccine group and 2279 (83%) in the placebo group. (elsevierpure.com)
  • The World Health Organization (WHO) recommends HPV vaccines as part of routine vaccinations in all countries, along with other prevention measures. (wikipedia.org)
  • These results suggest that behavioral health factors may be associated with vaccine acceptability and further our understanding of how behavioral patterns may contribute to the uptake of new cancer prevention strategies. (aacrjournals.org)
  • Its purpose is to inform clinicians in NYS who provide primary care to individuals with HIV about human papillomavirus (HPV)-related anal disease and assist them in identifying opportunities for prevention, screening, and treatment. (hivguidelines.org)
  • CodaVax RSV is an intranasal, live-attenuated vaccine candidate for the prevention of respiratory syncytial virus. (precisionvaccinations.com)
  • In a study of homosexual males, HPV vaccine was shown to be 78% effective in prevention of HPV 16- and 18-related anal intraepithelial neoplasms. (medscape.com)
  • The primary prevention represented by condom use and a quadrivalent vaccine for HPV, as well as the advent of new vaccines (such as the "nonavalente" vaccine) represent a technological advance in health and a gain for women's health in the short and long term 5 . (bvsalud.org)
  • The rotavirus vaccine minimally increases the rate of intussusception, whereas other vaccines minimally increase the risk of syncope. (aafp.org)
  • Their Rotarix vaccine is available in 36 Gavi countries to protect against rotavirus. (globalhealthprogress.org)
  • GARDASIL has not been studied in clinical trials with other vaccines. (constitutionwatch.com.au)
  • Randomised, placebo-controlled clinical trials are considered the gold standard for evaluating new vaccines. (umaryland.edu)
  • Standard recommendations for control recipients in trials testing an unlicensed, experimental vaccine include using either an inert substance or an approved efficacious vaccine. (umaryland.edu)
  • CoVepiT is a prophylactic vaccine candidate against COVID-19 based on optimized peptides selected to induce a lasting sentinel T lymphocyte immune response against SARS-CoV-2 in barrier tissues such as the respiratory tract and the lung. (precisionvaccinations.com)
  • Background/introduction Australia introduced the national quadrivalent human papillomavirus (4vHPV) vaccination programme in April 2007 in young women and included young boys in Feb 2013. (bmj.com)
  • Aim(s)/objectives To examine the prevalence of 4vHPV and the nine-valent (9vHPV) targeted vaccines genotypes among predominantly unvaccinated heterosexual men in Australia in 2004-2015. (bmj.com)
  • No change in 4vHPV in men from countries without any HPV vaccine programme. (bmj.com)
  • The originally recommended dosing schedule, 0, 2, 6 months, for the 3-dose quadrivalent human papillomavirus vaccine (4vHPV) was often not followed, resulting in longer than recommended intervals between doses and interest in the effect of prolonged intervals. (emmes.com)
  • Two doses of the vaccine may work as well as three doses. (wikipedia.org)
  • Because of this, parents have difficulty balancing the potential harms and benefits of vaccines. (aafp.org)
  • This film captures the essence of the vaccine debate: The benefits of vaccines for individuals as well as for society versus the very small but very real risks of a severe vaccine reaction. (greatergoodmovie.org)
  • Single-dose vials and manufacturer-filled syringes are designed for single-dose administration and should be discarded if vaccine has been withdrawn or reconstituted and subsequently not used within the time frame specified by the manufacturer. (cdc.gov)
  • The HPV vaccine is given as an injection into a muscle in a 2-dose or a 3-dose series. (msdmanuals.com)
  • COVI-VAC COVID-19 is a single-dose intranasal, live-attenuated vaccine candidate that is generated using Codagenix's proprietary deoptimization technology. (precisionvaccinations.com)
  • Eight Gavi countries are now using their new four-dose vial presentation of the Synflorix pneumococcal vaccine, designed to reduce cold chain challenges in countries. (globalhealthprogress.org)
  • GARDASIL is a ready-to-use, three-dose, intramuscular vaccine. (salesandmarketingnetwork.com)
  • That is below the expected and recommended by the WHO for the first and second dose ensuring the herd effect (benefits of the application of vaccines received by uninoculated people) 9 . (bvsalud.org)
  • These vaccines are expensive for developing countries (US$ 80 per dose with three doses required). (who.int)
  • As of 2022, 125 countries include HPV vaccine in their routine vaccinations for girls, and 47 countries also for boys. (wikipedia.org)
  • The Vaccine Adverse Event Reporting System and National Vaccine Injury Compensation Program track adverse events and allow compensation for documented harms from vaccinations. (aafp.org)
  • With the success of vaccinations, many parents no longer have contact with children who have vaccine-preventable illnesses. (aafp.org)
  • A nonavalent vaccine (Gardasil 9) is currently in production which will provide an even greater degree of protection (against 9 HPV types instead of 4: HPV 6/11/16/18/31/33/45/52/58). (nursinginpractice.com)
  • These results will be useful for preparing the introduction of the HPV vaccine in health ministry programmes. (who.int)
  • Ces résultats seront utiles pour préparer l'introduction du vaccin contre le papillomavirus humain dans les programmes du ministère de la santé. (who.int)
  • 5 In 2008, the HPV vaccination programme was introduced in the UK for girls aged 12 to 13, with catch-up programmes aiming to offer the vaccine to all girls born on or after September 1 1990. (nursinginpractice.com)
  • The COVID-19 Vaccine Moderna Intramuscular Injection is an mRNA vaccine targeted against the SARS-CoV-2 coronavirus encoding for a prefusion stabilized form of the Spike (S) protein authorized for use in Japan on May 21, 2021. (precisionvaccinations.com)
  • Gavi's five-year (2021-2025) strategy ('Gavi 5.0') envisions to 'leave no-one behind with immunization' and aims to save lives and protect people's health by increasing equitable and sustainable use of vaccines. (globalhealthprogress.org)
  • Results from clinical studies indicate that GARDASIL may be administered concomitantly (at a separate injection site) with hepatitis B vaccine (recombinant). (constitutionwatch.com.au)
  • Results: For the Hepatitis B vaccine, the prevalence of vaccinated patients was 81.33% (CI 95% 75.88 - 85.78). (usp.br)
  • Other solid performers in vaccines include GlaxoSmithKline, which placed five vaccines on the list, and Pfizer, whose vaccine Prevnar 13 topped the list with nearly $4 billion in sales last year. (genengnews.com)
  • Methods: 277 young women (mean age 20·2 years [SD 1·7]) were randomly assigned to quadrivalent HPV (20 μg type 6, 40 μg type 11, 40 μg type 16, and 20 μg type 18) L1 virus-like-particle (VLP) vaccine and 275 (mean age 20·0 years [1·7]) to one of two placebo preparations at day 1, month 2, and month 6. (johnshopkins.edu)
  • In total, 552 women (16-23 years) were enrolled in a randomised, placebo-controlled study of a quadrivalent HPV 6/11/16/18 L1 virus-like-particle vaccine with vaccination at months 0, 2, and 6. (vakciny.net)
  • ACIP recommends either vaccine for routine use in females aged 11 or 12 years ( 3 ). (cdc.gov)
  • Since 2006, HPV vaccine coverage in females has increased but remains low. (cdc.gov)
  • Antibody responses among adolescent females receiving two or three quadrivalent human papillomavirus vaccine doses at standard and prolonged intervals. (emmes.com)
  • However, national data indicate that only 37% of 13- to 17-year-old females have initiated the vaccine series. (aacrjournals.org)
  • Data from national and state surveys indicate that approximately one third of adolescent females have initiated the 3-shot HPV vaccine series ( 7 - 10 ). (aacrjournals.org)
  • 7-10 In developed countries such as the United States of America, vaccines against HPV were recommended for routine use in females aged 11 to 12 years. (who.int)
  • Intervention Three doses of quadrivalent HPV vaccine or placebo at day 1, month 2, and month 6. (sanevax.org)
  • METHODS: In this randomized, placebo-controlled, double-blind trial involving 5455 women between the ages of 16 and 24 years, we assigned 2723 women to receive vaccine and 2732 to receive placebo at day 1, month 2, and month 6. (elsevierpure.com)
  • 0·0001) in those assigned vaccine compared with those assigned placebo. (johnshopkins.edu)
  • Before implementing a large-scale HPV vaccine campaign in the south of Viet Nam, updated data on the prevalence and distribution of the vaccine types of HPV among women is required. (who.int)
  • Predictors of parents' acceptance of the HPV vaccine were living in precarious housing/slums and low household income (for mothers) and living in urban areas (for fathers). (who.int)
  • Behavioral factors significantly associated with lower acceptance of the HPV vaccine included lack of physical activity in the past month ( P = 0.002), past year use of complementary or alternative therapies ( P = 0.021), and no history of smoking ( P = 0.005). (aacrjournals.org)
  • Two vaccines are licensed and recommended for use in males (Gardasil and Gardasil 9). (cdc.gov)
  • a Critical Images slideshow, to help stay current with the latest routine and catch-up immunization schedules for 16 vaccine-preventable diseases. (medscape.com)
  • GARDASIL has not been shown to protect against diseases due to HPV types not contained in the vaccine. (salesandmarketingnetwork.com)
  • The new Vaccine technologies against transmissible and non-transmissible diseases, such as cancer, have had an impact on international public health. (bvsalud.org)
  • They have committed to deliver 720 million doses of their pneumococcal vaccine, Synflorix, to Gavi through the Advance Market Commitment (AMC) at a discounted price up to 2024. (globalhealthprogress.org)
  • From the text: The committee finds that evidence convincingly supports a causal relationship between some vaccines and some adverse events…evidence favors rejection of five vaccine-adverse event relationships… However, for the majority of cases (135 vaccine-adverse event pairs), the evidence was inadequate to accept or reject a causal relationship. (greatergoodmovie.org)
  • According to Dr N K Arora , Chairperson of the COVID working group, National Technical Advisory Group on Immunisation (NTAGI) said it is an exciting experience to launch a made-in-India vaccine. (indiatimes.com)
  • So, we will be able to take care of our requirements within our made-in-India vaccine," he said. (indiatimes.com)
  • Covaxin (BBV152, iNCOVACC) is an inactivated COVID-19 vaccine produced by Bharat Biotech located in Pune, India. (precisionvaccinations.com)
  • CoviShield (ChAdOx1) (AZD1222) is the Serum Institute of India COVID-19 vaccine. (precisionvaccinations.com)
  • Objective To examine factors associated with parents' uptake of human papillomavirus (HPV) vaccines for their children. (bmj.com)
  • Methods We included studies that sampled parents and assessed uptake of HPV vaccines for their children (≤18 years) and/or sociodemographics, knowledge, attitudes or other factors associated with uptake. (bmj.com)
  • Conclusions Findings indicate suboptimal levels of HPV vaccine uptake, twofold lower among boys, that may be improved by increasing physician recommendations, addressing parental safety concerns and promoting parents' positive beliefs about vaccines, in addition to expanding insurance coverage and reducing out-of-pocket costs. (bmj.com)
  • Further studies should disaggregate HPV vaccine uptake by sex of child and parent. (bmj.com)
  • This is the first systematic review and meta-analysis to focus on parents' uptake of human papillomavirus (HPV) vaccines for their children, more than 10 years after initial licensure of an HPV vaccine. (bmj.com)
  • Our findings provide pooled estimates of HPV vaccine uptake across 79 studies (n=840 838) conducted in 15 countries, indicating modest (41.5%) overall uptake with twofold higher uptake for girls than for boys. (bmj.com)
  • however, moderation analysis by risk of bias revealed no significant differences in HPV vaccine uptake. (bmj.com)
  • Some meta-analyses of correlates of parents' uptake of HPV vaccines for their children were based on relatively few studies, but we used random-effects models to compensate for clinical and methodological diversity among studies, and the majority of correlates were based on six or more primary studies. (bmj.com)
  • For administration of routinely recommended vaccines, there is no evidence of risk of exposure of vaccine components to the health care provider, so conditions in the provider labeled as contraindications and precautions to a vaccine components are not a reason to withdraw from this function of administering the vaccine to someone else. (cdc.gov)
  • The measles, mumps, and rubella vaccine does not increase the risk of autism and should be routinely used. (aafp.org)